EPM Therapeutics
- Biotech or pharma, therapeutic R&D
EPM Therapeutics is a US Biotechnology company focused on the development of proprietary, fully synthetic small molecule therapeutics to treat diseases with high unmet medical needs.
Our lead compound EPM301 is a first-in-class oral therapy for Prader-Willi Syndrome, and our non-clinical data package demonstrates its potential disease modifying impact on various aspects of PWS.
PWS is a rare pediatric disease with a high unmet medical need.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}